Bildkälla: Stockfoto

Respiratorius Q4’21: Outlook For 2022 – Structural Changes Ahead - Redeye

Redeye leaves its comment on Respiratorius following the year-end report. Structural changes are in front of the company, and with a guaranteed capital injection ahead, the company's financial position is solid, which is reassuring in the current market climate.

Redeye leaves its comment on Respiratorius following the year-end report. Structural changes are in front of the company, and with a guaranteed capital injection ahead, the company's financial position is solid, which is reassuring in the current market climate.
Börsvärldens nyhetsbrev
ANNONSER